Pages that link to "Q69564729"

The following pages link to The effect of maternal labetalol on the newborn infant (Q69564729):

Displaying 15 items.

• Adverse neonatal effects of maternal labetalol treatment (Q28369282) (← links)
• Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy (Q34416548) (← links)
• Studies on the effects of angiotensin II on human chorionic plate arteries and their modification by a calcium antagonist, nitrendipine (Q34416879) (← links)
• Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy (Q35704266) (← links)
• Changes in adrenoceptors and monoamine metabolism in neonatal and adult rat brain after postnatal exposure to the antihypertensive labetalol (Q35872368) (← links)
• Anesthesia, cardiopulmonary bypass, and the pregnant patient (Q37688875) (← links)
• In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review (Q38702465) (← links)
• Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy (Q42277000) (← links)
• The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia (Q43775103) (← links)
• Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension (Q51667224) (← links)
• Antihypertensive drugs in pregnancy (Q68218765) (← links)
• Half-life of maternal labetalol in a premature infant (Q69432342) (← links)
• Anesthetic management of preeclampsia/eclampsia (Q80473988) (← links)
• Hypertension in pregnancy (Q81201759) (← links)
• The effect of maternal ketanserin use on the circulation of the neonate: a prospective, observational study (Q83474019) (← links)